Xian-janssen Pharmaceutical Ltd.
Clinical trials sponsored by Xian-janssen Pharmaceutical Ltd., explained in plain language.
-
New hope for ulcerative colitis: Real-World study tests guselkumab in china
Disease control Recruiting nowThis study looks at how well guselkumab works for Chinese patients with moderate-to-severe ulcerative colitis who have never taken biologic medicines. Researchers will track 200 participants over 48 weeks to see if their symptoms improve in everyday medical practice. The goal is …
Sponsor: Xian-Janssen Pharmaceutical Ltd. • Aim: Disease control
Last updated May 14, 2026 12:14 UTC
-
New hope for Crohn's patients: drug switch may tame stubborn gut inflammation
Disease control Recruiting nowThis study tests whether guselkumab can help people with Crohn's disease whose current treatment (ustekinumab) has stopped working. About 78 Chinese adults with active Crohn's will receive guselkumab and be followed for 48 weeks. The main goal is to see if their symptoms improve …
Phase: PHASE4 • Sponsor: Xian-Janssen Pharmaceutical Ltd. • Aim: Disease control
Last updated May 08, 2026 12:03 UTC